Single Inhaler LABA/LAMA for COPD. - Abstract - Europe PMC
Future Pharmacology | Free Full-Text | Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions
Triple Therapy in COPD | Bentham Science
Bronchodilation is the cornerstone of treatment Pharmacological treatment of COPD. - ppt download
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
When to use the new LAB + LAMA combinations ? - ppt video online download
Frontiers | The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium | Multidisciplinary Respiratory Medicine
jcdr-15-FE01-g001.jpg
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Dual bronchodilator therapy: A review
1.3 Overview of Triple Therapy – Selected Topics in Health and Disease (Vol. 3)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Pharmacologic rationale underlying the therapeutic effects of tiotropi | TCRM
Single Inhaler LABA/LAMA for COPD | Semantic Scholar
Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs) | Journal of Medicinal Chemistry
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects. - Abstract - Europe PMC
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
Proven mechanisms of action leading to synergistic or additive... | Download Scientific Diagram
Interpreting Recent Developments in COPD Treatments - Document - Gale Academic OneFile
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy - ScienceDirect
